{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:51:20Z","timestamp":1790718680456,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.vaccine.2007.11.046","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T17:06:25Z","timestamp":1196960785000},"page":"863-868","source":"Crossref","is-referenced-by-count":46,"title":["After a tick bite in a tick-borne encephalitis virus endemic area: Current positions about post-exposure treatment"],"prefix":"10.1016","volume":"26","author":[{"given":"Michael","family":"Br\u00f6ker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.11.046_bib1","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in Southern Germany 1994\u20131998","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"issue":"S2","key":"10.1016\/j.vaccine.2007.11.046_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijmm.2005.12.005","article-title":"TBE incidence versus virus prevalence and increased prevalence of the TBE virus in Ixodes ricinus from humans","volume":"296","author":"S\u00fcss","year":"2006","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.11.046_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tmaid.2003.07.001","article-title":"New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad","volume":"1","author":"Br\u00f6ker","year":"2003","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.046_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10354-007-0424-8","article-title":"Tick borne encephalitis: From epidemiology to vaccination recommendations in 2007. New issues, best practices","volume":"157","author":"Kunze","year":"2007","journal-title":"Wiener Med. Wochenschrift"},{"issue":"S33","key":"10.1016\/j.vaccine.2007.11.046_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1438-4221(02)80011-X","article-title":"Vaccination against TBE in Austria The success story continues","volume":"291","author":"Kunz","year":"2002","journal-title":"Int J Med Microbiol"},{"issue":"S1","key":"10.1016\/j.vaccine.2007.11.046_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0264-410X(02)00814-9","article-title":"History of TBE vaccines","volume":"21","author":"Barrett","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.046_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.4.5.747","article-title":"Tick-borne encephalitis vaccines: past and present","volume":"4","author":"Br\u00f6ker","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.11.046_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/icb.1964.44","article-title":"Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls","volume":"42","author":"Hawkes","year":"1964","journal-title":"Aust J Exp Biol Med Sci"},{"key":"10.1016\/j.vaccine.2007.11.046_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/0022-1317-65-8-1261","article-title":"Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate","volume":"65","author":"Gollins","year":"1984","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.11.046_bib10","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1099\/0022-1317-71-12-2909","article-title":"Measurement of antibody infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies","volume":"71","author":"Morens","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.11.046_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4049\/jimmunol.127.2.659","article-title":"Growth of 17 D yellow fever virus in a macrophage-like cell-line. U937: role of Fc and viral receptors in antibody-mediated infection","volume":"127","author":"Schlesinger","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.046_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jmv.1890080204","article-title":"Antibody-mediated infection of macrophages and macrophage like cell lines 17D-Yellow fever virus","volume":"8","author":"Schlesinger","year":"1981","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2007.11.046_bib13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1099\/0022-1317-66-8-1831","article-title":"Antibody-dependent enhancement of tick-borne encephalitis virus infectivity","volume":"66","author":"Phillpotts","year":"1985","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.11.046_bib14","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/JVI.71.4.2921-2927.1997","article-title":"Pre- and post-exposure protection by immunoglobulin but no enhancement of infection with a flavivirus in a mouse model","volume":"71","author":"Kreil","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.11.046_bib15","first-page":"1806","article-title":"Aktive und passive Immunprophylaxe der Fr\u00fchsommer-Meningoencephalitis (FSME)","volume":"28","author":"Kunz","year":"1978","journal-title":"Arzneim-Forsch"},{"key":"10.1016\/j.vaccine.2007.11.046_bib16","first-page":"1837","article-title":"FSME-Immunglobulin \u2013 eine kritische Beurteilung der Wirksamkeit","volume":"124","author":"Aebi","year":"1994","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.vaccine.2007.11.046_bib17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(95)92527-9","article-title":"Tickborne encephalitis despite specific immunoglobulin prophylaxis","volume":"346","author":"Kluger","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.11.046_bib18","unstructured":"Kaiser R und die Teilnehmer der Expertenkonferenz. Fr\u00fchsommermeningoenzephalitis und Lyme-Borreliose \u2013 Pr\u00e4vention vor und nach Zeckenstich. Dtsch Med Wschr. 1998;123:847\u201353."},{"key":"10.1016\/j.vaccine.2007.11.046_bib19","unstructured":"Anonymous. Fr\u00fchsommer-Meningoencephalitis (FSME). Erkennung und Verh\u00fctung. Released by BgVV und RKI; 1996."},{"key":"10.1016\/j.vaccine.2007.11.046_bib20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(96)90977-0","article-title":"Do specific hyperimmuneglobulins aggravate clinical course of tick-borne encephalitis?","volume":"347","author":"Arras","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.11.046_bib21","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.vaccine.2006.10.028","article-title":"Tick-born encephalitis (TBE) vaccination: applying the most suitable vaccination schedule","volume":"25","author":"Sch\u00f6ndorf","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.046_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/hv.3.2.3747","article-title":"Tick-borne encephalitis (TBE) vaccination in children. Advantage of the rapid immunization schedule (i.e., days 0, 7, 21)","volume":"3","author":"Schoendorf","year":"2007","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2007.11.046_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0264-410X(92)90003-3","article-title":"A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens","volume":"10","author":"Harabacz","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.046_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(84)90809-2","article-title":"Immune response to single dose, multisite, intradermal and to intramuscular administration of vaccine against tick-borne encephalitis virus","volume":"324","author":"Zoulek","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.11.046_bib25","unstructured":"Wittermann C, Nicolay U, Schoendorf I. Tick-borne encephalitis (TBE) vaccines for children. Data on safety and immunogenicity using different immunization schedules and vaccines. Proceedings of the 25th annual meeting of the society for paediatric infectious diseases, Porto, May 2\u20134, Poster 410."},{"key":"10.1016\/j.vaccine.2007.11.046_bib26","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.046_bib27","unstructured":"Impfplan 2007. \u00d6sterreich. Empfehlungen des Obersten Sanit\u00e4tsrates (Impfausschuss: 21. November 2006). http:\/\/www.bmgf.gv.at."},{"key":"10.1016\/j.vaccine.2007.11.046_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2310\/7060.2004.19107","article-title":"Risk and prevention of tick-borne encephalitis in travelers","volume":"11","author":"Rendi-Wagner","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2007.11.046_bib29","unstructured":"Ghem HE, Gittermann M, Fankhauser H, Michot M., A fatal tick bite between the first two TBE (FSME) immunizations. Proceedings of the annual meeting of the Swiss society for paediatrics, Z\u00fcrich, June 14\u201315, 2007, poster presentation."},{"key":"10.1016\/j.vaccine.2007.11.046_bib30","first-page":"439","article-title":"Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC) rabies vaccine in man","volume":"265","author":"Scheiermann","year":"1987","journal-title":"Zbl Bakt Hyg A"},{"key":"10.1016\/j.vaccine.2007.11.046_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccine for use in man: a four-vaccine comparative immunogenicity study of using a pre-exposure vaccination schedule and an abbreviated 2-1-1 post-exposure schedule","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T04:56:21Z","timestamp":1684126581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07013497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0264410X07013497"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}